Cynthia Crawford Green
Cardiovascular Disease · Oxon Hill, MDNPI 1841281011
Payments from drug & device makers
Across 198 payments — averaging $24.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Impulse Dynamics (USA) Inc.$514
- Novartis$481
- Boehringer Ingelheim$349
- Gilead$299
- Pfizer$245
- plus $2K from 24 others
What the payments were for
- Speaking & faculty fees$3507%
- Food & beverage$4,59593%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 21 | $1,158 |
| Impulse Dynamics (USA) Inc. | 3 | $514 |
| Novartis | 33 | $481 |
| Boehringer Ingelheim | 16 | $349 |
| Gilead | 22 | $299 |
| Pfizer | 11 | $245 |
| AstraZeneca | 13 | $223 |
| Johnson & Johnson | 10 | $220 |
| Amgen | 8 | $214 |
| Novo Nordisk | 10 | $188 |
| Lilly USA, LLC | 8 | $148 |
| Kowa Pharmaceuticals America, Inc. | 5 | $125 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Merck | 4 | $74 |
| Hikma Pharmaceuticals USA | 4 | $71 |
| Philips North America LLC | 2 | $71 |
| Zealand Pharma US, Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| Arbor Pharmaceuticals, Inc. | 3 | $52 |
| Smith+Nephew | 3 | $48 |
| Boston Scientific | 2 | $42 |
| Amarin Pharma, Inc. | 2 | $34 |
| Eyevance Pharmaceuticals LLC | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Atricure, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| AbbVie | 1 | $14 |
| Infobionic, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIMIZER$700
- CardioMEMS HF System$616
- Assurity Pacemaker$265
- Repatha$122
- OPTIMIZER SMART SYSTEM$109
How this compares
$4,945 in reported general payments places this provider in the 65th percentile of 507 cardiovascular disease providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $9,167 |
| Rosuvastatin Calcium | 38 | $919 |
| Nebivolol Hcl | 18 | $664 |
| Furosemide | 18 | $144 |
| Atorvastatin Calcium | 13 | $135 |
| Amlodipine Besylate | 26 | $98 |
| Hydrochlorothiazide | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanumet | $74 | $9,16711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 507 cardiovascular disease providers in Maryland.
Other cardiovascular disease in Oxon Hill
- Christopher DefilippiBaltimore$9.2M
- Thorsten LeuckerBaltimore$7.1M
- Joao LimaBaltimore$5.6M
- Jeffrey ColeBaltimore$4.8M
- Carlos InceBaltimore$3M
- Paul GurbelBaltimore$2.6M
- Navin KapurBaltimore$1.8M
- Vineet VenugopalLanham$1.5M
- Robert WeissBaltimore$1.4M
- Stephen GottliebBaltimore$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.